Fosaprepitant and Ifosfamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fosaprepitant (fosaprepitant) and Ifosfamide (ifosfamide). Common drug interactions include clonic convulsion among females and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people have when they take Fosaprepitant and Ifosfamide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Fosaprepitant?
Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.
What is Ifosfamide?
Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.
16 people who take Fosaprepitant and Ifosfamide together, and have interactions are studied.

What are the common drug interactions of Fosaprepitant and Ifosfamide, by gender? *:
female:
- Clonic convulsion (long lasting seizure)
- Confusional state
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Decreased activity
- Eye movement disorder
- Headache (pain in head)
- Hypotension (abnormally low blood pressure)
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Moaning (a low, sustained, mournful cry)
- Neutropenia (an abnormally low number of neutrophils)
male:
- Febrile neutropenia (fever with reduced white blood cells)
- Malaise (a feeling of general discomfort or uneasiness)
- Myelosuppression (a decrease in the production of blood cells)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- White blood cell count decreased
What are the common drug interactions of Fosaprepitant and Ifosfamide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Clonic convulsion (long lasting seizure)
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Eye movement disorder
- Headache (pain in head)
- Oesophagitis (inflammation of oesophagus)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
- Unresponsive to stimuli
- Malaise (a feeling of general discomfort or uneasiness)
- Myelosuppression (a decrease in the production of blood cells)
20-29:
n/a
30-39:
- Confusional state
- Decreased activity
- Febrile neutropenia (fever with reduced white blood cells)
- Moaning (a low, sustained, mournful cry)
- Screaming (a long loud piercing cry)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tinnitus (a ringing in the ears)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech)
40-49:
n/a
50-59:
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Bacteraemia (presence of bacteria in the blood)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
60+:
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Neutropenia (an abnormally low number of neutrophils)
- Anaemia (lack of blood)
- Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
- Hypotension (abnormally low blood pressure)
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 5 people, 31.25%
- Pain: 5 people, 31.25%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 25.00%
- Constipation: 4 people, 25.00%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 25.00%
- Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 25.00%
- Headache (pain in head): 3 people, 18.75%
- Nausea And Vomiting: 3 people, 18.75%
- Generalised Oedema (swelling all over the body): 2 people, 12.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Fosaprepitant and Ifosfamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Fosaprepitant (1,178 reports)
- Ifosfamide (21,285 reports)
Browse all drug interactions of Fosaprepitant and Ifosfamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fosaprepitant:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ifosfamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fosaprepitant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ifosfamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on fosaprepitant and ifosfamide (the active ingredients of Fosaprepitant and Ifosfamide, respectively), and Fosaprepitant and Ifosfamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Carbidopa And Levodopa cause Posture Abnormal? - now
- Could Oxaliplatin cause Mouth Ulcers? - 2 seconds ago
- Could Abilify cause Skin Warm? - 9 seconds ago
- Could Methylprednisolone cause Growth Retardation? - 12 seconds ago
- Drug interactions of Genotropin and Bisacodyl - 14 seconds ago
- Crohn'S Disease and Blindness Transient - 17 seconds ago
- Drug interactions of Ammonium Lactate and Combigan - 23 seconds ago
- Drug interactions of Vitamin B6 and Mysoline - 40 seconds ago
- Drug interactions of Gemfibrozil and Propulsid - 41 seconds ago
- Drug interactions of Brimonidine Tartrate and Levaquin - 43 seconds ago